Close Menu

NEW YORK (GenomeWeb News) – Helicos BioSciences today said that it has hired investment bank Thomas Weisel partners to assist the firm in evaluating and executing strategic alternatives, such as financings, joint ventures, or partnerships.

The firm also provided a round-up of second-quarter highlights, most of which was disclosed in its quarterly filing with the US Securities and Exchange Commission on Aug. 14.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet has made changes to its peer-review process in response to its recent retraction of a COVID-19-related paper, Science reports.

The New York Times reports that a series of emails show how Department of Health and Human Services officials sought to silence the Centers for Disease Control and Prevention.

A new initiative aims to move Australia's genome sequencing labs onto one system, the Sydney Morning Herald reports.

In PLOS this week: recessive mutation tied to early-onset dilated cardiomyopathy, epigenetic analysis of lung adenocarcinoma, and more.

Sep
24
Sponsored by
ArcherDX

NTRK fusions are oncogenic drivers in a variety of tumors.